Furthermore, they observed that tau aggregates shared many characteristics with NFTs from AD patients’ brains and they were shown to cause synapse loss, neurite retraction, an imbalance in neurotransmitter release, as well as abnormal Ca2+ homeostasis in the iPSC-derived neurons [82]. The gene discussed is MAPT; the disease is Alzheimer disease.